Gene: ZBTB37
Official Full Name: zinc finger and BTB domain containing 37provided by HGNC
Gene Summary: Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Predicted to be located in chromatin. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24777 | ZBTB37 Knockout cell line (HeLa) | Human | ZBTB37 | 1:3~1:6 | Negative | Online Inquiry |
KO24778 | ZBTB37 Knockout cell line (HCT 116) | Human | ZBTB37 | 1:2~1:4 | Negative | Online Inquiry |
KO24779 | ZBTB37 Knockout cell line (HEK293) | Human | ZBTB37 | 1:3~1:6 | Negative | Online Inquiry |
KO24780 | ZBTB37 Knockout cell line (A549) | Human | ZBTB37 | 1:3~1:4 | Negative | Online Inquiry |
ZBTB37 Gene Knockout Cell Lines are genetically modified cellular models specifically engineered to have a disrupted ZBTB37 gene, which encodes a zinc finger protein involved in various biological processes, including transcriptional regulation and cellular differentiation. By utilizing CRISPR-Cas9 technology, these knockout cell lines offer researchers a precise tool to investigate the role of ZBTB37 in cellular functions and disease mechanisms, particularly in the contexts of cancer and immune response regulation.
The key function of ZBTB37 includes modulating gene expression by binding to specific DNA sequences, thus functioning as a transcriptional repressor. By knocking out this gene, researchers can observe changes in cellular behavior, gene expression profiles, and pathways, thereby elucidating the biological impact of ZBTB37 deficiency. This makes the ZBTB37 knockout cell lines an invaluable resource in both basic and applied research settings.
In scientific research, understanding the ramifications of ZBTB37 knockout provides insights into its potential roles in pathologies such as hematological disorders and certain cancers, where altered gene expression can contribute to tumorigenesis or immune dysregulation. These cell lines also serve as critical tools in the development of targeted therapies or novel treatments, offering a platform for drug discovery and efficacy testing.
Compared to traditional methods, such as RNA interference or loss-of-function assays, ZBTB37 gene knockout cell lines provide a more robust and permanent solution to study gene function, allowing for the observation of long-term effects of ZBTB37 depletion. Their specificity and durability enhance experimental reproducibility and reliability in results.
For researchers and clinicians striving to uncover the complexities of genetic regulation and disease, ZBTB37 Gene Knockout Cell Lines represent cutting-edge tools that enhance the understanding of gene function in human health. Our company specializes in providing high-quality genetic products that empower scientists with the resources needed to advance their research, and we are committed to supporting innovation through rigorous quality assurance and expert customer service.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.